ACE and diabetes mellitus: Because RAS inhibition has been demonstrated to reduce the incidence of new diabetes in randomized trials, prescription of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers has the most reliable evidence base for reducing the incidence of diabetes at an individual level.